MENU
OCT 12 2017 - OCT 13 2020

Stago EdVantage Virtual University


Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that explore basic and complex concepts, making them accessible to novices as well as experienced users.  In an ever evolving landscape of research and publication, it can be challenging to stay current. By listening to industry key opinion leaders and Stago experts, you can be assured of staying informed of the latest best practices.

Benefits of the Stago EdVantage Virtual University comprehensive online webcast library include being able to access programs 24/7, participate in complete trainings on-the-go with our mobile compatible platform, train at your leisure with stop and start capability, and receive instantaneous training certificates upon completion.  With Stago EdVantage Virtual University, you can maintain education and accreditation requirements at no cost, on demand and on your schedule, so you can participate more frequently and implement new tools more rapidly.
 
Diagnostica Stago has long placed a high priority on hemostasis education. We are glad you have chosen to attend Stago EdVantage Virtual University.


Speakers
  • System Director - Anticoagulation and Clinical Thrombosis Services
  • Division Chief for Laboratory Medicine, Department of Laboratories, Seattle Children's Hospital; Clinical Professor of Laboratory Medicine, University of Washington
  • Laboratory New Venture Developer and Value Specialist
  • Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital
  • Clinical Laboratory Scientist
  • QA Manager for Specialty Testing Supervisor, Special Coagulation and Hematology, New York Presbyterian Hospital
  • Medical Director, UHS Pathology Services, University Health System; Professor, Clinical Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio
  • Chair and Professor, Medicine (primary) Professor, Clinical Epidemiology and Biostatistics (Associate) Leo Pharma Chair in Thromboembolism Research
  • Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
  • Supervisory Medical Technologist, Associate Professor in the College of Clinical Laboratory Science at Oklahoma Christian University
  • Professor of Medicine, UNC-Chapel Hill Hemophilia & Thrombosis Center
  • Professor and Physician Scientist, McMaster University and Head of Coagulation for the Hamilton Regional Laboratory Medicine Program
  • Assistant Professor in the Department of Pathology, Interim Director of Blood Bank, and Associate Director of Coagulation Laboratory at the University of Chicago Medical Center
  • Professor of Anesthesiology, Professor of Surgery (Cardiothoracic), CoDirector, Cardiothoracic ICU, Duke University Hospital
  • Program Director for Anticoagulation Services, Sanford USD Medical Center & Clinical,Associate Professor, Dept of Internal Medicine, University of South Dakota Sanford School of Medicine

Show Resources
Webinars

Stago is committed to providing you with the latest relevant information regarding new tests, new markers or key assays in the field of Thrombosis and Haemostasis. Educational sessions are provided by healthcare professionals and international world-renowned experts in the field. 

  • WORLD THROMBOSIS DAY SPECIAL EVENT:  The Use of D-dimer as a Novel Biomarker in Venous Thromboembolic Disease for Hospitalized Medically Ill Patients
    OCT 13, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Alex Spyropoulos, MD, FACP, FCCP, FRCPC
    System Director - Anticoagulation and Clinical Thrombosis Services
    Sponsored By: Diagnostica Stago, Inc.
  • Thromboembolism in COVID-19 Laboratory Considerations
    JUN 30, 2020 8:00 AM PDT
    Michael P Gulseth, PharmD, BCPS, FMSHP, FASHP
    Program Director for Anticoagulation Services, Sanford USD Medical Center & Clinical,Associate Professor, Dept of Internal Medicine, University of South Dakota Sanford School of Medicine
  • The International Council for Standardisation in Hematology (ICSH) recommendations for Hemostasis Critical Values, Tests, and Reporting - a stepwise description for the committee's decisions
    APR 24, 2020 8:00 AM PDT
    Bob Gosselin
    Clinical Laboratory Scientist
  • APR 22, 2020 8:00 AM PDT
    Eleanor J Herriman, MD, MBA
    Laboratory New Venture Developer and Value Specialist
    Oksana Volod, MD
    Associate Professor of Pathology at the Cedars Sinai Me...
  • Emergency patient management using coagulation assays
    APR 20, 2020 8:00 AM PDT
    Wayne L. Chandler, MD
    Division Chief for Laboratory Medicine, Department of Laboratories, Seattle Children's Hospital; Clinical Professor of Laboratory Medicine, University of Washington
  • Emerging Issues in the Coagulation Laboratory
    FEB 05, 2020 8:00 AM PST
    Donna D. Castellone, MS, MASCP, MT(ASCP) SH
    QA Manager for Specialty Testing Supervisor, Special Coagulation and Hematology, New York Presbyterian Hospital
  • Challenges in hemostasis test standardization
    SEP 09, 2019 8:00 AM PDT
    Russell Aaron Higgins, MD
    Medical Director, UHS Pathology Services, University Health System; Professor, Clinical Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio
    Sponsored By: Diagnostica Stago, Inc.
  • VTE Diagnosis: Case-Based Update on D-dimer and ASH 2018 Clinical Practice Guidelines
    APR 26, 2019 12:00 AM PDT
    Suman M Wasan MD, MS
    Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
    Sponsored By: Diagnostica Stago, Inc.
  • Case Studies in the Coagulation Laboratory
    APR 24, 2019 12:00 AM PDT
    Donna D. Castellone, MS, MASCP, MT(ASCP) SH
    QA Manager for Specialty Testing Supervisor, Special Coagulation and Hematology, New York Presbyterian Hospital
    Sponsored By: Diagnostica Stago, Inc.
  • Direct Oral Anti-Coagulant (DOAC) Measurement Focusing on Anti-Xa, and Recent DOAC Trial Updates
    APR 22, 2019 12:00 AM PDT
    Mark Crowther , MD, MSc, FRCPC
    Chair and Professor, Medicine (primary) Professor, Clinical Epidemiology and Biostatistics (Associate) Leo Pharma Chair in Thromboembolism Research
    Sponsored By: Diagnostica Stago, Inc.
  • Hemostasis lab quality best practices; focus on validation of assays and instrumentation in a multisite hospital system
    JAN 15, 2019 8:00 AM PST
    Jana Gausman, MT (ASCP)
    Supervisory Medical Technologist, Associate Professor in the College of Clinical Laboratory Science at Oklahoma Christian University
    Sponsored By: Diagnostica Stago, Inc.
  • Lupus Anticoagulant Testing: Managing Interferences and Optimizing Quality
    AUG 08, 2018 8:00 AM PDT
    Geoffrey D. Wool, MD, PHD
    Assistant Professor in the Department of Pathology, Interim Director of Blood Bank, and Associate Director of Coagulation Laboratory at the University of Chicago Medical Center
    Sponsored By: Diagnostica Stago, Inc.
  • Testing for Coagulation Factor Deficiencies and Inhibitors
    APR 27, 2018 8:00 AM PDT
    Catherine Hayward, MD PhD FRCPC
    Professor and Physician Scientist, McMaster University and Head of Coagulation for the Hamilton Regional Laboratory Medicine Program
    Sponsored By: Diagnostica Stago, Inc.
  • Quality in the Coagulation Laboratory
    APR 25, 2018 8:00 AM PDT
    Donna D. Castellone, MS, MASCP, MT(ASCP) SH
    QA Manager for Specialty Testing Supervisor, Special Coagulation and Hematology, New York Presbyterian Hospital
    Sponsored By: Diagnostica Stago, Inc.
  • UFH monitoring focusing on use of anti-Xa for critically ill and general patient management
    APR 23, 2018 8:00 AM PDT
    Jerrold H Levy, MD, FAHA, FCCM
    Professor of Anesthesiology, Professor of Surgery (Cardiothoracic), CoDirector, Cardiothoracic ICU, Duke University Hospital
    Sponsored By: Diagnostica Stago, Inc.
  • Direct Oral Anticoagulant Screening and Measurement for Challenging Patient Cases
    APR 26, 2017 6:00 AM PDT
    Michael P Gulseth, PharmD, BCPS, FMSHP, FASHP
    Program Director for Anticoagulation Services, Sanford USD Medical Center & Clinical,Associate Professor, Dept of Internal Medicine, University of South Dakota Sanford School of Medicine
    Sponsored By: Diagnostica Stago, Inc.
  • Heparin Monitoring: aPTT versus Anti-Xa assay
    FEB 07, 2017 6:00 AM PST
    Donna D. Castellone, MS, MASCP, MT(ASCP) SH
    QA Manager for Specialty Testing Supervisor, Special Coagulation and Hematology, New York Presbyterian Hospital
    Sponsored By: Diagnostica Stago, Inc.
Speakers

  • Alex Spyropoulos, MD, FACP, FCCP, FRCPC
    System Director - Anticoagulation and Clinical Thrombosis Services
    Biography
      Alex C. Spyropoulos, MD received his medical degree from the University of Pennsylvania School of Medicine in Philadelphia, PA. He completed his internship and residency in internal medicine at the University of New Mexico Health Sciences Center in Albuquerque, NM. He is board certified in Internal Medicine.
      Dr. Spyropoulos was Founder and former Medical Director of the Clinical Thrombosis Center in Albuquerque, New Mexico. He is a Professor of Medicine at Hofstra, Northwell School of Medicine and System Director of Anticoagulation and Clinical Thrombosis Services for the multi hospital Northwell Health System in NY. He is also a Professor of the Center for Health Innovations and Outcomes Research as part of the Feinstein Institute for Medical Research. He is co-chair of the Council on Leadership of Thrombosis at Northwell Health System. He is a Fellow of the American College of Physicians, American College of Chest Physicians, International Academy of Clinical and Applied Thrombosis/Haemostasis, and the Royal College of Physicians, Canada.
      Dr. Spyropoulos has helped to develop protocols using LMWH in outpatient-based treatment of venous thromboembolic disease, patient self-testing of warfarin, perioperative “bridging” for patients on chronic anticoagulation, medical inpatient thromboprophylaxis, protocols with regards to the use of anticoagulants for HIT, and clinical use of the direct oral anticoagulants (DOAC), including their use in special patient populations and periprocedural situations. Dr. Spyropoulos is active in assessing outcome and pharmacoeconomic analyses of these protocols and has lectured extensively both nationally and internationally on these issues.
      He has been involved as Principal Investigator, Scientific Committee member, Steering and Executive Committee member, or member of Data Safety Monitoring Board in multiple international, multicenter randomized trials in thrombosis and anticoagulant therapy, including the NHLBI BRIDGE and NHLBI Kids DOTT studies and the CIHR PAUSE trial. He was the co-Principal Investigator for MARINER, a global Phase 3 multicenter study of thromboprophylaxis in medical patients. He is a founding member of ATLAS, a US-based ARO-CRO in thrombosis-related research. He is a panel member of a US national experts consensus group for clinical excellence in thrombosis management, a Steering Committee member for World Thrombosis Day as part of the International Society of Thrombosis and Haemostasis (ISTH), he is Chair of the Scientific and Standardization Committee of ISTH on the Diagnosis, Prevention, and Treatment of COVID-19 Thrombosis, a member of the Global COVID-19 Thrombosis Collaborative Group, co-Chair of the Scientific and Standardization Committees of Perioperative Thrombosis and Haemostasis of ISTH, a member of the Anticoagulation Forum and the Thrombosis/Haemostasis Society of North America, , and co-author for the 8th, 9th and currently 10th 2020 ACCP Guidelines on Perioperative Antithrombotic Therapy, co-author of the 2008 International Consensus Statement Guidelines in Venous Thromboembolism, and senior author for the 2013 International Consensus Statement on venous thromboembolic disease. He is also reviewer for the 2014 ESC Guidelines on Pulmonary Embolism and the 2020 American College of Physicians Statement on Pulmonary Embolism Treatment.
      Dr Spyropoulos has been very active in thrombosis-related issues with COVID-19 disease. He chaired the 2020 Guidance Statement of Scientific and Standardization Committee of the ISTH for the diagnosis, prevention, and treatment of VTE in hospitalized COVID-19 patients. He was an active member of the Global COVID-19 Thrombosis Collaborative Group which has published 2 major international guidance statements in COVID-19 and thrombosis-related issues. He is the Principal Investigator of the Hep-COVID trial, an investigator-initiated multicenter randomized controlled trial comparing treatment-dose LMWH versus standard-of-care prophylactic or intermediate-dose heparin in the prevention of major thromboembolism and death in sick hospitalized COVID-19 patients. He is also Principal Investigator of the CORE-19 registry, one of the largest registries of 11,200 patients assessing thromboembolic and other outcomes both in-hospital and post-discharge for COVID-19 patients. He is an Executive Committee member of the PREVENT-HD trial, a large 4000-5000 patients placebo-controlled randomized trial assessing the efficacy and safety of thromboprophylaxis using a DOAC in sick outpatients with COVID-19. He is the lead investigator in a large thromboembolic outcome study of over 10.871 hospitalized COVID-19 patients at Northwell Health. He has published over 10 articles, editorials, and letters for major journals related to COVID-19 and thrombosis.
      He is Section Editor for Thrombosis and Haemostasis, and is on the editorial staff for Hospital Medicine. He is a reviewer for many journals.
      Dr. Spyropoulos’ research studies, articles, letters, and editorials have been published in over 210 peer-reviewed journals including The New England Journal of Medicine, Blood, Blood Advances, Circulation, Lancet Hematology, Lancet, Annals of Internal Medicine, American Journal of Hematology, JAMA Internal Medicine, American Journal of Medicine, Chest, Thrombosis Haemostasis, American Journal of Cardiology, Journal of Thrombosis and Haemostasis , Journal of the American College of Cardiology, Clinical Applied Thrombosis and Haemostasis, and Thrombosis Research.
    • Wayne L. Chandler, MD
      Division Chief for Laboratory Medicine, Department of Laboratories, Seattle Children's Hospital; Clinical Professor of Laboratory Medicine, University of Washington
      Biography
        Wayne L. Chandler, MD is currently Division Chief for Laboratory Medicine, Department of Laboratories at Seattle Children's Hospital and Clinical Professor of Laboratory Medicine at the University of Washington. He received his undergraduate degree from the University of Utah, his medical degree from St. Louis University School of Medicine, and completed a residency in Clinical Pathology at the University of Washington. He worked in the Department of Laboratory Medicine at the University of Washington for 20 years and for 4 years in the Department of Pathology and Genomic Medicine at Houston Methodist Hospital. His clinical practice and research focuses on diagnostic testing for hemostatic and thrombotic disorders.
      • Eleanor J Herriman, MD, MBA
        Laboratory New Venture Developer and Value Specialist
        Biography
          Dr. Eleanor J. Herriman is a laboratory new venture developer and value specialist. She is a physician executive with 20 years of varied healthcare industry experience. Previously she was Chief Medical Informatics Officer at Viewics, Inc. Eleanor was also a faculty member at Harvard Business School's Institute for Strategy and Competitiveness. Prior career experience includes: market research and strategy services to the pathology and laboratory industries at G2 Intelligence, healthcare strategy consulting at Bain & Company, and multiple startup medical technology ventures. Dr. Herriman holds a Doctor of Medicine degree from Baylor College of Medicine and was awarded the Presidents Scholarship. Dr Herriman also holds a Masters in Business Administration from Harvard University Graduate School of Business Administration as a Baker Scholar and a Bachelors of Science in electrical engineering from Rice University with a minor in bioengineering.
        • Oksana Volod, MD
          Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital
          Biography
            Oksana Volod, MD is Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital in Los Angeles, CA. She is responsible for the coagulation laboratory and works extensively across multiple departments to ensure best patient testing practices. Her clinical research interests include viscoelastic test utilization for personalized treatment of complex coagulopathies and development of optimal anticoagulation strategies for patients on mechanical circulatory support devices (MCS). In addition, she is a member of the Coagulation Resource Committee of the College of American Pathologists (CAP). Prior to her current position, she performed her residency in Anatomic and Clinical Pathology, along with a fellowship in hematopathology and coagulation at CSMC. She was also a visiting fellow in coagulation at the Royal Free Hospital in London, UK and previously earned her MD at the Uzhgorod State University in Ukraine.
          • Bob Gosselin
            Clinical Laboratory Scientist
            Biography
              I am a licensed Clinical Laboratory Scientist in the state of California having retired from the University of California, Davis Health System (UCDHS) in 2017 after 30 years of service, with the last 23 years as the Sr Specialist in Special Coagulation section of the Pathology and Laboratory Medicine department. I currently serve as a staff volunteer with the Hemostasis & Thrombosis Center at UCDHS and the Thrombosis Subcommittee for UCDHS, a working group of the institution's Pharmacy and Therapeutics committee. I serve on the board and several committees for the International Council for Standardisation in Hematology (ICSH) and a former board member for the North American Specialized Coagulation Laboratory Association (NASCOLA) and the International Society for Laboratory Hematology (ISLH). I also serve as an associate editor for the Journal of Thrombosis and Haemostasis, former associate editor for the International Journal for Laboratory Hematology (IJLH), and currently serve as editorial board member for Seminars in Thrombosis and Hemostasis and the IJLH. I have authored or co-authored 99 articles, and 5 book chapters, with the most recent manuscripts focusing on laboratory testing of direct oral anticoagulants and laboratory quality issues.
            • Donna D. Castellone, MS, MASCP, MT(ASCP) SH
              QA Manager for Specialty Testing Supervisor, Special Coagulation and Hematology, New York Presbyterian Hospital
              Biography
                Donna is Quality Assurance (QA) Manager, Specialty Testing Supervisor, Special Coagulation and Special Hematology at New York Presbyterian Hospital- Columbia in New York City. She has 34 years clinical laboratory experience, 6 years industry clinical trial experience, including PhD work on Standardization of Laboratory Testing (all but dissertation). Donna has written several book chapters, many publications and presented many coagulation lectures to diverse audiences at all levels of expertise. She is adjunct professor at York College and Rutgers University. Donna presently serves on the Executive Committee of the North American Specialized Coagulation Laboratory Association (NASCOLA) as a Secretary, Publication Committee and Pre-Curriculum Committee for the American Society for Clinical Pathology (ASCP), and the Expert Committee for Hematology for the Clinical Laboratory Standards Institute (CLSI). She is also a member of International Society on Thrombosis and Haemostasis (ISTH), International Society for Laboratory Hematology (ISLH) and ASCP.
              • Russell Aaron Higgins, MD
                Medical Director, UHS Pathology Services, University Health System; Professor, Clinical Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio
                Biography
                  Russell A. Higgins, MD is a Clinical Professor of Pathology and Laboratory Medicine at the University of Texas Health San Antonio. He received his undergraduate degree from the New Mexico Tech in 1996 and his medical degree from the University of New Mexico School of Medicine in 2002. He completed a residency in Anatomic and Clinical Pathology in 2006 and a fellowship in hematopathology at the University of Texas Health San Antonio in 2008. Dr Higgins is the Medical Director of University Hospital System Pathology Services and the Section Chief of the Hematology and Coagulation Laboratory at University Hospital in San Antonio. Dr. Higgins has developed expertise in laboratory quality issues in hemostasis. He has been a member and chair of the CAP Coagulation Resource Committee, CAP liaison to the International Society for Thrombosis and Hemostasis (ISTH) and External Quality Assurance in Thrombosis and Hemostasis (EQATH), member of the CAP Pharmacogenetics Subcommittee, co-Chair of the North American Specialized Coagulation Laboratories (NASCOLA) Platelet Committee, and a contributor to the FDA Network of Experts.
                • Mark Crowther , MD, MSc, FRCPC
                  Chair and Professor, Medicine (primary) Professor, Clinical Epidemiology and Biostatistics (Associate) Leo Pharma Chair in Thromboembolism Research
                  Biography
                    Dr Crowther's research interests include improving the way we use current anticoagulant drugs. These include exploring established and novel interventions to mitigate bleeding, and studies of currently available anticoagulant drugs in high-risk patient populations. Dr Crowther's work also focusses on developing systematic reviews of key questions in Hematology and Thrombosis, and basing Guidelines on those reviews. Dr Crowther has more than 400 peer reviewed publications, was inducted into the Royal Society of Canada in 2017, and received the 2017 International Society of Thrombosis and Haemostasis BACH Investigator Recognition Award. He was one of 14 scientists from the Michael G. DeGroote School of Medicine at McMaster University cited by Clarivate Analytics on its Highly Cited Researchers list (formerly known as Thomson Reuter's annual publication of The World's Most Influential Scientific Minds). Dr Crowther is currently the Chair, Department of Medicine at McMaster University and holds the Leo Pharma Chair in Thromboembolism Research at McMaster University.
                  • Suman M Wasan MD, MS
                    Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
                    Biography
                      Suman Rathbun, MD is currently Director of the Vascular Medicine Program at OUHSC as well as director of the vascular laboratories and vascular fellowship at OU Medical Center, Oklahoma City, Oklahoma. Dr. Rathbun has been principal investigator in several research projects regarding pulmonary embolism and deep-vein thrombosis. Dr. Rathbun has published and presented both locally and nationally. She participated on the U.S. Surgeon General's task force for awareness of deep-vein thrombosis in Washington, DC. Currently, she serves as secretary to the Society of Vascular Medicine and chair of the education committee for the Venous Disease Coalition. Suman Rathbun received her doctorate of medicine at the University of Texas at San Antonio, Texas in 1994. Dr. Rathbun received her master's degree in epidemiology at the University of Oklahoma Health Sciences Center in 2004. She is board certified in internal medicine and vascular medicine.
                    • Jana Gausman, MT (ASCP)
                      Supervisory Medical Technologist, Associate Professor in the College of Clinical Laboratory Science at Oklahoma Christian University
                      Biography
                        Jana Gausman, MT(ASCP) is a Supervisory Medical Technologist overseeing a Specialty Coagulation and Hematology Laboratory in Oklahoma City, Ok. Ms. Gausman also is an executive committee member with the North American Specialized Coagulation Laboratory Association (NASCOLA). She is an Associate Professor in the College of Clinical Laboratory Science at Oklahoma Christian University.
                      • Stephan Moll, MD
                        Professor of Medicine, UNC-Chapel Hill Hemophilia & Thrombosis Center
                        Biography
                          Dr. Moll received his medical degree from Freiburg University, Germany, He completed an internship/residency in internal medicine and a hematology-oncology fellowship at Duke University Medical Center (1989-1996), during which he also did a 1-year clinical coagulation fellowship at the University of North Carolina, Chapel Hill (1994-1995). Dr. Moll's postgraduate career included a position in clinical coagulation in the cardiology division of the Humboldt University in Berlin, Germany (1997-1999). Dr. Moll has been a faculty member at UNC in the Department of Medicine and the Division of Hematology-Oncology since 1999. His clinical focus is coagulation, particularly thrombosis and thrombophilia. Dr. Moll's research interests include clinical trials on new anticoagulants, better use of established anticoagulants, antiphospholipid antibody syndrome and postthrombotic syndrome. He has a major interest in health education of patients, public and health care providers about blood clots and clotting disorders. Since 2001 he has written a Q/A section on thrombosis and thrombophilia for the non-profit website www.fvleiden.org. Dr. Moll is a co-founder of the national patient advocacy group NBCA (National Blood Clot Alliance; www.stoptheclot.org), and a board member of the national non-profit anticoagulation provider organization AC-Forum (Anticoagulation Forum; www.acforum.org). He has authored and coauthored a number of peer-reviewed articles textbook chapters on blood clots. He is the founder of the UNC Blood Clot Education Outreach Program created in 2010.
                        • Catherine Hayward, MD PhD FRCPC
                          Professor and Physician Scientist, McMaster University and Head of Coagulation for the Hamilton Regional Laboratory Medicine Program
                          Biography
                            Dr. Hayward is a Professor and Physician Scientist at McMaster University and is also the Head of Coagulation for the Hamilton Regional Laboratory Medicine Program. She is also the President of the International Society of Laboratory Hematology. Dr. Hayward has published extensively in the field of hemostasis, including studies on using laboratory tests to diagnose bleeding disorders and her publications have been cited more than 7100 times. Dr. Hayward has received many awards including Gold Medal awards from McMaster University and the Royal College of Physician and Surgeons for her research on hemostasis, a Canada Research Chair and Heart and Stroke Foundation Career Investigator Awards, and the Berend Houwen and Biggs McFarlane Lecture Awards. She is passionate about education and promoting best diagnostic laboratory practices.
                          • Geoffrey D. Wool, MD, PHD
                            Assistant Professor in the Department of Pathology, Interim Director of Blood Bank, and Associate Director of Coagulation Laboratory at the University of Chicago Medical Center
                            Biography
                              Dr Geoffrey Wool is assistant professor in the department of pathology, Interim Director of Blood Bank, and Associate Director of Coagulation Laboratory at the University of Chicago Medical Center. Prior to his current positions, he completed his fellowship in transfusion medicine at University of Chicago, fellowship in hematopathology at University of California San Francisco, and was a resident physician in the department of pathology and laboratory medicine. He earned an MD and PhD from University of Chicago and a BA from University of California, Berkeley. Dr Wool has published 18 peer-reviewed publications in areas of lupus anticoagulant testing, anticoagulant monitoring, platelet defects, and transfusion medicine, is a reviewer for multiple journals, has written several educational book chapters on different areas of pathology, as well as attending numerous research conferences where he presented oral or poster presentations.
                            • Jerrold H Levy, MD, FAHA, FCCM
                              Professor of Anesthesiology, Professor of Surgery (Cardiothoracic), CoDirector, Cardiothoracic ICU, Duke University Hospital
                              Biography
                                Dr. Jerrold Levy is Professor of Anesthesiology and Surgery (Cardiothoracic) and Co-director of the Cardiothoracic Surgical Intensive Care Unit at Duke University Medical Center. He obtained his medical degree from the University of Miami, and undertook his residency and fellowships at the Massachusetts General Hospital and Harvard Medical School, Boston. His clinical and research interests include therapeutic strategies to prevent and treat bleeding; anticoagulation and its reversal, clinical applications of recombinant and purified protein concentrates, therapeutic approaches to shock/ventricular dysfunction, and anaphylaxis.
                              • Michael P Gulseth, PharmD, BCPS, FMSHP, FASHP
                                Program Director for Anticoagulation Services, Sanford USD Medical Center & Clinical,Associate Professor, Dept of Internal Medicine, University of South Dakota Sanford School of Medicine
                              C.E. Credits

                              The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                              Sponsored by

                              For information on becoming a sponsor or exhibitor, please click here.


                              Help

                              General LabRoots Questions

                              email support@labroots.com  

                              Virtual Events and Webinars

                              Supported Configurations

                              • Operating System Internet Explorer Firefox Chrome Safari
                                Vista IE8+ FF10+ Chrome15+
                                Windows 7 IE8+ FF10+ Chrome15+
                                Windows 8 IE10 FF10+ Chrome15+
                                Mac OS X   FF10+ Chrome15+ Safari5.1+
                              • Cookie settings: session cookies enabled
                              • Browser configuration must have JavaScript enabled
                              • Adobe Flash player 10.2 or later

                              To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                              Internet Connection

                              • A minimum of 100Kbps is recommended for audio-only events
                              • A minimum of 300Kbps is recommended for speaker on-video events

                              Computer Equipment

                              • Screen Resolution: Minimum 1024x768
                              • Video Card: 65,000 colors minimum
                              • Sound card and speakers (or headphones) for hearing webcast in full format
                              • Audio Card: 16-bit minimum
                              • RAM: 512MB of free RAM

                              Firewall Protocol

                              • HTTP on port 80 or HTTPS on port 443
                              • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                              • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                              Work-At-Home Attendees

                              • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                              For A Seamless Experience

                              When using a mobile device, FREE Mobile Apps are available:

                              - For viewing Webinars:

                              - For viewing Virtual Events

                              Attendee Guide

                              • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                              Virtual Event and Webinar Support:

                              Continuing Education (CME/CE) Support

                              Show Resources
                              Attendees
                              • See more
                              Resources